TNFSF13B and inflammatory bowel disease: This is the first study to compare the efficacy of faecal BAFF with faecal calprotectin and FOBT for discriminating IBS from IBD and assessment of intestinal inflammation in IBD after we identified BAFF as a novel biomarker in IBD16.